Summary
This prediction ended on 14.12.24 with a price of €180.35. The BUY prediction by BiotechBee finished with a performance of 12.05%. BiotechBee has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| UCB S.A. | 3.799% | 3.799% | 57.766% |
| iShares Core DAX® | -1.756% | 1.667% | 2.099% |
| iShares Nasdaq 100 | 2.324% | 12.779% | 38.808% |
| iShares Nikkei 225® | 5.022% | 13.300% | 60.099% |
| iShares S&P 500 | 0.802% | 6.198% | 25.356% |
According to BiotechBee what are the pros and cons of UCB S.A. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread UCB S.A. diskutieren
Buy mit Kursziel 210,0